Cargando…
Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
This study aims to evaluate the factors influencing the adherence to the 2nd and 3rd doses of Amodiaquine (AQ) during seasonal malaria chemoprevention (SMC) in Burkina Faso, Mali, and Niger. Overall, 3132 people were interviewed during surveys between 2019 and 2020 in 15 health districts. In Burkina...
Autores principales: | Somé, Anyirékun Fabrice, Zongo, Issaka, Sagara, Issaka, Ibrahim, Alkassoum, Ahanhanzo, Césaire Damien, Agbanouvi-agassi, Edoh Eddie, Sayi, Dona Alain, Toe, Lea Pare, Kabré, Zachari, Nikiéma, Frédéric, Bazié, Thomas, Ouédraogo, Sylvin, Sombié, Issiaka, Dicko, Alassane, Adehossi, Eric, Ouédraogo, Jean-Bosco, Dabiré, Kounbobr Roch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503675/ https://www.ncbi.nlm.nih.gov/pubmed/36136625 http://dx.doi.org/10.3390/tropicalmed7090214 |
Ejemplares similares
-
Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
por: Compaoré, Yves Daniel, et al.
Publicado: (2021) -
Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2016) -
Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2018) -
Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
por: Zongo, Issaka, et al.
Publicado: (2020) -
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
por: Greenwood, Brian, et al.
Publicado: (2017)